Pharma Components ApS: Financial statements 2024
CVR: 39103079
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharma Components ApS (CVR 39103079) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 336,413 and a net result of DKK 142,048 compared with DKK 196,140 the year before. That is an increase of 44.9% compared with the year before. Equity in the 2024 report amounted to DKK 387,566. The solvency ratio was 48.1%.
- Gross Profit
- DKK 336,413
- Profit/Loss
- DKK 142,048
- Equity
- DKK 387,566
- Total Assets
- DKK 805,450
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 336 t. | 142 t. | 388 t. | 0 |
| 2023 | - | 232 t. | 196 t. | 246 t. | 0 |
| 2022 | - | 69 t. | 57 t. | 49 t. | 0 |
| 2021 | - | -22 t. | -23 t. | -8 t. | 0 |
| 2020 | - | -17 t. | -15 t. | 15 t. | 0 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharma Components ApS has published its annual report for 2023. Gross profit came to DKK 232,225, and the net result was DKK 196,140.
About Pharma Components ApS
Pharma Components ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named Pharma Components IVS. The management consists of Anders Fossing Riel. The company is owned by A.Rocket Holding ApS. In 2025, the company reported a gross profit of DKK -35,183 and a net result of DKK -115,173 compared with DKK 142,048 the year before. Equity in the 2025 report amounted to DKK 272,393.